Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma
| Conditions: | Mesothelioma |
| Start Date: | September 1, 2009 |
| Phase: | Phase II |
| Status: | Recruiting |
| NCT ID: | NCT00996385 |
| Study Type: | Interventional |
| Intervention: | Drug: Velcade (bortezomib) plus Eloxatin (oxaliplatin) |
| Study Design: | Allocation: Non-Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Columbia University |
| Ages: | Adult|Senior |
| Enrollment: | 29 |
| Funded By: | Other |
| First Received: | October 14, 2009 |
| End Date: | September 1, 2014 |
| Last Updated: | October 13, 2010 |
| Last Verified: | October 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
